Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; Influenza; Vaccination rate; Predictors; Inflammatory rheumatic disease; CI; Confidence Interval; DMARD; disease-modifying antirheumatic drug; EULAR; The European League against Rheumatism; GP; General Practitioner; HIV; Human Immunodeficiency Virus; IVR;
مقالات ISI داروهای ضد رماتیسمی اصلاح کننده بیماری (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; Rheumatoid arthritis; Inflammation; Methotrexate; Prodrug; Thiazolidinone; Reactive oxygen species; ADMET; absorption, distribution, metabolism, excretion, toxicity; CFA; Complete Freund's Adjuvant; CIA; collagen-induced arthritis; CL'int; apparent intrin
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; RA; rheumatoid arthritis; TCZ; tocilizumab; TOFA; tofacitinib citrate; MTX; methotrexate; DMARD; disease-modifying antirheumatic drug; bDMARD; biologic disease-modifying antirheumatic drug; nbDMARD; non-biologic disease-modifying antirheumatic drug; obDMA
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; Biologics; Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis; AEs; adverse events; CD; Crohn's disease; DMARDs; disease-modifying antirheumatic drug; IBD; inflammatory bowel disease; MTX; methotrexate; RA; rheumatoid arthritis; RTX; rit
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; Rheumatoid arthritis; Serious infection; Mannose binding lectin; Immune system; Risk factor; bDMARD; Biologic disease-modifying antirheumatic drug; COPD; Chronic obstructive pulmonary disease; CS; Corticosteroids; DMARD; Disease-modifying antirheumatic dr
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; anti-CCP; anti-cyclic citrullinated peptide antibody; BMI; body mass index; CCL20; CC chemokine ligand 20; C/EBPβ; CCAAT-enhancer-binding protein β; CRP; C-reactive protein; CSF1R; colony stimulating factor 1 receptor; DAS28; disease activity score 28;
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; CAD; coronary artery disease; CNS; central nervous system; DMARD; disease-modifying antirheumatic drug; HR; hazard ratio; ICD-9-CM; International Classification of Disease, Ninth Revision, Clinical Modification; NHIRD; National Health Insurance Research D
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; Biologic agents; adverse effect; infection; autoimmunity; paradoxical inflammation; ANA; Antinuclear antibody; AS; Ankylosing spondylitis; DMARD; Disease-modifying antirheumatic drug; IBD; Inflammatory bowel disease; ILD; Interstitial lung disease; NTM; N
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; AE; adverse event; ACR; American College of Rheumatology; Apo; apolipoprotein; BID; twice daily; BP; blood pressure; CHF; congestive heart failure; CRP; C-reactive protein; csDMARD; conventional synthetic disease-modifying antirheumatic drug; CV; cardiova
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; DMARD; disease-modifying antirheumatic drug; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; IPTW; inverse probability treatment weight; MCO; managed care organization; PS; propensity score; VSD; Vaccine Safety D
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; ACPA; anticitrullinated protein antibody; CCP; cyclic citrullinated peptide; CTD; connective tissue disease; CXCL; CXC chemokine ligand; Dlco; diffusing capacity of lung for carbon monoxide; DMARD; disease-modifying antirheumatic drug; HRCT; high resoluti
Biologic Disease-modifying Antirheumatic Drug Attributes in the First Lines of Treatment of Rheumatoid Arthritis. 2015 ACORDAR Project
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; Characteristic; Arthritis; Biologic; Disease-modifying antirheumatic drug; Selection; CaracterÃsticas; Artritis; Biológico; Fármaco antirreumático modificador de la enfermedad; Selección;
Comorbidity of Type 1 Diabetes Mellitus in Patients with Juvenile Idiopathic Arthritis
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; JIA; type 1 diabetes mellitus prevalence; autoimmune diseases; DMARDs; observational study; AID; Autoimmune disease; AIT; Autoimmune thyroiditis; bDMARD; Biological DMARD; BMI; Body mass index; CD; Celiac disease; cJADAS; Clinical Juvenile Arthritis Disea
IL-1 receptor antagonist (IL-1Ra)-Fc ameliorate autoimmune arthritis by regulation of the Th17 cells/Treg balance and arthrogenic cytokine activation
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; ACR; American College of Rheumatology; APC; allophycocyanin; CD; cluster of differentiation; CIA; collagen induced arthritis; CII; type II collagen; CTLA-4; cytotoxic T-lymphocyte antigen 4; DMARD; disease-modifying antirheumatic drug; ELISA; enzyme-linke
Pregnancy outcomes following exposure to abatacept during pregnancy
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; Pregnancy; Abatacept; Exposure; Congenital anomalies; Biological disease-modifying antirheumatic drugs; DMARD; disease-modifying antirheumatic drug; FDA; Food and Drug Administration; MADCF; Metropolitan Atlanta Congenital Defects Program; MMF; mycophenol
Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain - Interleukin-8 in fibromyalgia and interleukin-1 β in rheumatoid arthritis
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; HRV; heart rate variability; RA; rheumatoid arthritis; FM; fibromyalgia; CSF; cerebrospinal fluid; IL; interleukin; IL-1Ra; interleukin 1 receptor antagonist; TNF; tumor necrosis factor; CCL-2; chemokine (C-C motif) ligand 2; BDNF; brain-derived neurotr
Healthcare Utilization and Comorbidity Burden among Children and Young Adults in the United States with Systemic Lupus Erythematosus or Inflammatory Bowel Disease
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; DMARD; Disease-modifying antirheumatic drug; IBD; Inflammatory bowel disease; ICD-9-CM; International Classification of Diseases, 9th Revision-Clinical Modification; SLE; Systemic lupus erythematosus;
Initial Management of Rheumatoid Arthritis
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; Rheumatoid arthritis; Disease-modifying antirheumatic drug; DMARD;
My Treatment Approach to Rheumatoid Arthritis
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; ACPA; anti-citrullinated protein antibody; ACR; American College of Rheumatology; BeSt; Behandel-Strategieën [trial]; CDAI; Clinical Disease Activity Index; CRP; C-reactive protein; CTLA-4:Ig; cytotoxic T lymphocyte-associated antigen 4:immunoglobuli
Power of crowdsourcing: Novel methods of data collection in psoriasis and psoriatic arthritis
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; crowdsource; crowdsourcing; data collection; psoriasis; psoriatic arthritis; treatment; ACR-20; at least 20% improvement in symptoms based on American College of Rheumatology (ACR) criteria; ACR-50; at least 50% improvement in symptoms based on ACR criter
Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; Mechanism of action; Rheumatoid arthritis; Systemic lupus erythematosus; Sjögren's syndrome; Biomarker; B cell-targeting drugs; ACPA; anti-citrullinated peptide antibody; ACR; American College of Rheumatology; APRIL; a proliferation-inducing ligand; BCMA
Remitting Seronegative Symmetrical Synovitis With Pitting Edema Syndrome in a Rural Tertiary Care Practice: A Retrospective Analysis
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; ANA; antinuclear antibody; DMARD; disease-modifying antirheumatic drug; ESR; erythrocyte sedimentation rate; GC; glucocorticoid; PMR; polymyalgia rheumatica; RS3PE; remitting seronegative symmetrical synovitis with pitting edema;
Genetics of Rheumatoid Arthritis
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; AICAR-T; aminoimidazole carboxamide ribonucleotide transformylase; CRH; corticotropin-releasing hormone; DMARD; disease-modifying antirheumatic drug; IL; interleukin; MHC; major histocompatibility complex; MTHFR; methylenetetrahydrofolate reductase; RA; r
Rheumatoid Arthritis: A Disease Associated with Accelerated Atherogenesis
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; rheumatoid arthritis; atherogenesis; inflammatory response; endothelial dysfunction; carotid intima-media thickness; cardiovascular complications; mortality; apoLp; apolipoprotein; BMI; body mass index; CV; cardiovascular; CRP; C-reactive protein; DAS; di
Rheumatoid arthritis: A review of the cutaneous manifestations
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; CIC; circulating immune complex; DMARD; disease-modifying antirheumatic drug; ESR; erythrocyte sedimentation rate; HLA; human leukocyte antigen; JRA; juvenile rheumatoid arthritis; LCV; leukocytoclastic vasculitis; MTX; methotrexate; NSAID; nonsteroidal a
Diagnosis and treatment of psoriatic arthritis
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; ACR; American College of Rheumatology; DIP; distal interphalangeal; DMARD; disease-modifying antirheumatic drug; ESR; erythrocyte sedimentation rate; FDA; Food and Drug Administration; HAQ; health assessment questionnaire; HLA; human leukocyte antigen; Ig